Pharmacokinetics (How Long They Last): Semaglutide: Half-life: Approximately 7 days Reaches steady state: After 4-5 weeks Duration of action: Remains active for one week between doses Time to peak concentration: 1-3 days after injection Tirzepatide: Half-life: Approximately 5 days Reaches steady state: After 4 weeks Duration of action: Remains active for one week between doses Time to peak concentration: 8-72 hours after injection Both medications are designed for once-weekly dosing and maintain therapeutic levels throughout the week
Aim for a mix of aerobic exercises (like walking, running, or cycling) and strength training (like weightlifting or resistance exercises)
(Industry coverage of Eli Lilly's December 2025 TRIUMPH-4 topline announcement, including the 28.7% body weight loss figure on 12mg, the 2.1% placebo figure, and the schedule for remaining 2026 readouts.) Eli Lilly and Company
Now, Amazon One Medical kiosks will offer Foundayo, which allows individuals to access their prescriptions on the same day after speaking with a healthcare professional
The one-month results patterns seen with semaglutide provide a useful comparison for what to expect with retatrutide, though the triple mechanism typically accelerates results once therapeutic doses are reached
Comparison to Other Diabetes Medications How do GLP-1 medications compare to other options for glucose control